Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.80) per share. This is a 91.82 percent increase over losses of $(9.78) per share from the same period last year.
Related Posts
AMD Stock Is Gaining Tuesday: Here’s Why
Advanced Micro Devices, Inc (NASDAQ:AMD) shares are trading higher Tuesday following Daniel Loeb’s hedge fund Third Point disclosed new stakes in AMD. As…
JD.com CEO Lei Xu To Retire For Personal Reasons, Current CFO Sandy Ran Xu Promoted To CEO and Exec. Director, JD Logistics CFO Ian Su Shan Promoted To JD CFO
D.com, Inc. ("JD.com" or the "Company") (NASDAQ:JD), a leading supply chain-based technology and service provider, is pleased to announce today that Ms. Sandy Ran Xu, the current chief financial
Daimler Truck Q1 Revenues Surge 25% On Continued Higher Demand, 2023 Outlook Reaffirmed
Daimler Truck Holding (NYSE:DTRUY) reported a Q1 2023 revenue increase of 25% Y/Y to €13.2 billion. The top line benefitted…